​

The Aptima™ SARS-CoV-2 assay is a nucleic acid amplification in-vitro diagnostic test intended for the qualitative detection of RNA from SARS-CoV-2 isolated and purified from nasopharyngeal (NP), nasal, mid-turbinate, and oropharyngeal (OP) swab specimens, nasopharyngeal wash/ aspirate or nasal aspirates obtained from individuals meeting COVID-19 clinical and/or epidemiological criteria.

​

Features:

• Authorized for use in both symptomatic and asymptomatic people.

• Power of sensitivity: Most analytically sensitive, fully-automated, high-throughput

• molecular test.

• Flexible: A single patient specimen can be tested for SARS-CoV-2 as well as other

• common respiratory viruses with symptoms that overlap with COVID-19 boosting efficiency and increasing clinical insight.

​

Benefits:

• For use with nasopharyngeal (NP), nasal, mid-turbinate, and oropharyngeal (OP) swab specimens, nasopharyngeal wash/aspirate, or nasal wash.

✓ Viral transport medium (VTM/UTM)
✓ Saline
✓ Liquid Amies
✓ Specimen transport medium (STM)
✓ Aptima® Multitest Swab Specimen Collection Kit

Click Here for more product information on our partner site